AVNS
Avanos Medical Inc
NYSE: AVNS · HEALTHCARE · MEDICAL DEVICES
$24.73
+0.20% today
Updated 2026-06-05
Market cap
$1.17B
P/E ratio
—
P/S ratio
1.64x
EPS (TTM)
$-1.60
Dividend yield
—
52W range
$9 – $25
Volume
1.7M
WallStSmart proprietary scores
37
out of 100
Grade: D
Sell
Investment rating
4.0
Growth
C7.0
Quality
B+3.5
Profitability
D5.0
Valuation
C+4/9
Piotroski F-Score
Moderate
1.2
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$14.00
-43.39%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
Price chart
Stock snapshot
Strengths
+ Debt/equity 0.18x — low leverage
Risks
- Altman Z 1.24 — distress zone
- Thin margins at -10.40%
- Negative free cash flow $-16.60M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $684.10M | $673.30M | $687.80M | $701.20M | $715.90M |
| Net income | $50.50M | $-61.80M | $-392.10M | $-67.90M | $5.10M |
| EPS | — | — | — | — | $-1.60 |
| Free cash flow | $71.60M | $14.60M | $82.90M | $43.10M | $-16.60M |
| Profit margin | 7.38% | -9.18% | -57.01% | -9.68% | -10.40% |
Recent insider activity
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-03-13 | PACITTI, DAVID | Buy | 239,354 | — |
| 2026-03-13 | PACITTI, DAVID | Buy | 101,341 | — |
| 2026-03-13 | HURLEY, JOHN JOSEPH | Buy | 2,211 | — |
Peer comparison
Smart narrative
Avanos Medical Inc trades at $24.73. Our Smart Value Score of 37/100 indicates the stock is weak. The company scores 4/9 on the Piotroski F-Score. With an Altman Z-Score of 1.24, it sits in the distress. TTM revenue stands at $715.90M. with profit margins at -10.40%.
Frequently asked questions
What is Avanos Medical Inc's stock price?
Avanos Medical Inc (AVNS) trades at $24.73, on a P/S of 1.6x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is Avanos Medical Inc overvalued?
Avanos Medical Inc carries a Smart Value Score of 37/100 (Grade D), which we rate Sell. That score blends growth, quality, and valuation into one read.
What is the price target of Avanos Medical Inc (AVNS)?
The 12-month analyst consensus target is $14.00, about 43.4% below the current $24.73. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
What is Avanos Medical Inc's revenue?
Avanos Medical Inc's trailing twelve-month revenue is $715.90M. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.
Altman Z-Score?
Avanos Medical Inc's Altman Z-Score is 1.24, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryMEDICAL DEVICES
CountryUSA
ExchangeNYSE
CurrencyUSD
Quick metrics
P/S ratio1.64x
ROE-8.87%
Beta1.59
50D MA$21.47
200D MA$14.56
Shares out0.05B
Float0.05B
Short ratio—
Avg volume1.7M
Performance
1 week+4.38%
1 month+5.14%
3 months+22.41%
YTD+29.39%
1 year—
3 years—
5 years—